Antigens Biomarkers Products & Reviews

2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6)

COVID-19, MERS & SARS-CoV, Nucleoprotein Antibody, 1057

COVID-19, MERS & SARS-CoV, Nucleoprotein Antibody, 1058

SARS-CoV-2 Nucleocapsid, clone 504 Monoclonal Antibody (matched pair with clone 502 or 503)

SARS-CoV-2 Nucleocapsid, clone 2A1 Monoclonal Antibody (matched pair with clone 2C1)

SARS-CoV-2 Nucleocapsid, clone 2C1 Monoclonal Antibody (matched pair with clone 2A1)

SARS-CoV-2 Nucleocapsid, clone 4D8 Monoclonal Antibody (matched pair with clone 5B7)

SARS-CoV-2 Nucleocapsid, clone 5B7 Monoclonal Antibody (matched pair with clone 4D8)

SARS-CoV-2 Nucleocapsid,clone 7B3 Monoclonal Antibody (matched pair with clone 5D4)

SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, 613

SARS-CoV-2 Spike (RBD, aa 331-524) Recombinant Antigen

SARS-CoV-2 Spike Protein S1 (aa 1-674) Recombinant Antigen

Use the Bio-Plex Pro Human Serology Reagent when performing Bio-Plex Pro singleplex or combined (multiplexed) assays with Bio-Plex SARS-CoV-2 N, RBD, S1, and/or S2, and/or nucleocapsid coupled magnetic beads and Human IgA, IgG, or IgM detection in human and non-human primate samples.

Provides sensitive and specific quantitation of antibodies against four SARS-CoV-2 proteins: nucleocapsid, receptor binding domain, spike 1, and spike 2 viral proteins.  

Biomarker Detection System

Biomarker Measurement Detection

Protein Biomarker Testing and Custom Assay Development Services

pTau181 Biomarker Assay

Glial Fibrillary Acidic Protein (GFAP) is a class-III intermediate filament majorly expressed in astrocytic glial cells in the central nervous system. Astrocytes play a variety of key roles in supporting, guiding, nurturing, and signaling neuronal architecture and activity. Monomeric GFAP is about 55kD. It is capable of forming both homodimers and heterodimers; GFAP can polymerize with other type III proteins or with neurofila…

The Simoa Human Neurology 4-Plex E (N4PE) assay simultaneously measures four biomarkers in EDTA plasma and CSF. The targets are Abeta 40 (Aβ40), Abeta 42 (Aβ42), Glial Fibrillary Acidic Protein (GFAP™), and Neurofilament light (Nf-L). Each biomarker has been demonstrated to have significance for the investigation of neurodegeneration and brain injury, and to have utility for monitoring effectiveness of drug discovery and devel…

The Simoa Human Neurology 2-Plex assay (N2PB) measures two important neurology biomarkers in both cerebrospinal fluid (CSF) and blood. The two targets are neurofilament light (Nf-L) and glial fibrillary acidic protein (GFAP™), which have been studied as indicators of traumatic brain injury (TBI) severity. N2PB has been developed as a 2-Plex version of the Neurology 4-Plex B assay (N4PB). *Banyan GFAP™ is a registered tradem…

Sino Biological provides a wide range of influenza virus research reagents and technical services, supporting vaccine safety and immunogenicity assessment and vaccine protective efficacy evaluation.

Sino Biological provides comprehensive solutions for CAR-T cell therapy companies from CAR development, T cell activation, lentivirus packaging, CAR-T cell expansion to CAR-T cell quality control, fully supporting CAR-T research.

Sino Biological has developed a series of high-quality research reagents for dominant SARS-CoV-2 mutants, including recombinant antigens, detection antibodies, ELISA kits, pseudovirus, cDNAs, peptide pools, and receptor ACE2. These variant reagents have actively supported the basic research of SARS-CoV-2 and the development of vaccines, therapeutic antibodies, and diagnostic reagents.

Sino Biological provides comprehensive reagents and services for CAR-NK cell therapy development to support our customers from early target discovery to the preclinical phase of research and development.